205Bi/206Bi cyclotron production from Pb-isotopes for absorption studies in humans

This publication has 13 references indexed in Scilit:

• Bismuth Absorption from²⁰⁵Bi-Labelled Pharmaceutical Bismuth Compounds Used in the Treatment of Peptic Ulcer Disease
  Scandinavian Journal of Gastroenterology, 1992
• Bioavailability of bismuth from205Bi-labelled pharmaceutical oral Bi-preparations in rats
  Archives of Toxicology, 1991
• Absorption and elimination of bismuth from oral doses of tripotassium dicitrato bismuthate
  European Journal of Clinical Pharmacology, 1989
• Cyclotron production of no-carrier-added 206Bi (6.24 d) and 205Bi (15.31 d) as tracers for biological studies and for the development of alpha-emitting radiotherapeutic agents
  Applied Radiation and Isotopes, 1987
• Bismuth-212-labeled anti-Tac monoclonal antibody: alpha-particle-emitting radionuclides as modalities for radioimmunotherapy.
  Proceedings of the National Academy of Sciences, 1986
• Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents
  Antimicrobial Agents and Chemotherapy, 1985
• Nuclear orientation and NMR/ON of205,207Po
  The European Physical Journal A, 1983
• The large-scale production of carrier-free 206Bi for medical application
  The International Journal of Applied Radiation and Isotopes, 1975
• Uptake of²⁰⁶Bi Citrate in Carcinoma of the Breast
  Radiology, 1973
• CROSS SECTIONS OF (p, xn) REACTIONS IN THE ISOTOPE OF LEAD AND BISMUTH
  Canadian Journal of Physics, 1956